Contents -- Part I: Clinical presentations: approaches to problems -- 1 Dyspnea -- Clinical assessment and causes -- Specific situations -- 2 Chronic cough and normal chest X-ray -- Etiology, clinical assessment, and treatment -- Causes of chronic cough: UACS -- Causes of chronic cough: asthma, NAEB -- Causes of chronic cough: GERD -- Causes of chronic cough: chronic bronchitis, bronchiectasis, ACE inhibitors -- Causes of chronic cough: miscellaneous -- Further information -- 3 Chest pain -- Chest pain: overview -- Acute chest pain -- Chronic chest pain -- 4 Hemoptysis -- Clinical assessment and causes -- Investigations -- Management of massive hemoptysis -- 5 Unexplained respiratory failure -- Causes -- Clinical assessment and management -- 6 Pleural effusion -- Clinical assessment -- Diagnostic algorithm for the patient with a pleural effusion -- Transudative pleural effusions -- Exudative pleural effusions -- Pleural fluid analysis 1 -- Pleural fluid analysis 2 -- 7 Diffuse parenchymal lung disease -- Causes -- Clinical assessment and imaging -- HRCT diagnosis -- Further investigations -- 8 Diffuse alveolar hemorrhage -- 9 Pulmonary infiltrates in the immunocompromised host (non- HIV) -- Clinical assessment -- Further investigations -- Causes -- Treatment -- 10 Pulmonary infiltrates in the immunocompromised host (HIV) -- Introduction -- Causes of respiratory disease in HIV infection -- 11 The respiratory sleep patient -- History -- Examination and investigations -- 12 The breathless, pregnant patient -- Causes -- Investigations -- 13 Preoperative assessment of the pulmonary patient -- 14 Postoperative breathlessness -- Part II: Clinical conditions -- 15 Asthma -- Definition, epidemiology, pathophysiology, etiology -- Diagnosis -- Investigations -- Asthma exacerbations -- Acute severe or life-threatening asthma -- Treatment of acute asthma.

Chronic asthma: management -- Nonpharmacological therapies -- "Difficult/refractory" asthma -- Asthma in pregnancy -- Occupational asthma -- Management of occupational asthma -- Vocal cord dysfunction -- Allergic rhinitis (hay fever) -- 16 Chronic obstructive pulmonary disease (COPD) -- Definition, etiology, pathology, and clinical features -- Investigations -- Nonpharmacological management of stable COPD -- Pharmacological management of stable COPD -- Management of exacerbations -- Summary of approaches to medical treatment -- Surgical treatment -- 17 Lung cancer -- Epidemiology and types -- Clinical features -- Investigations -- Diagnostic procedures -- Staging -- Non-small cell lung cancer ( NSCLC): surgery -- NSCLC: chemotherapy -- NSCLC: radiotherapy -- Small cell lung cancer: treatment -- Superior vena caval obstruction (SVCO): etiology and clinical assessment -- SVCO: management -- Hypercalcemia -- Syndrome of inappropriate ADH secretion (SIADH) -- Spinal cord compression -- Pulmonary carcinoid tumors -- Pulmonary nodules -- Lung cancer screening -- 18 Mediastinal abnormalities -- Anatomy -- Mediastinal abnormalities -- 19 Bacterial respiratory infection -- Community-acquired pneumonia (CAP) -- CAP: clinical features -- CAP: severity assessment -- CAP: investigations -- CAP: management -- CAP: antibiotics -- CAP: treatment failure -- CAP: follow-up -- Hospital-acquired pneumonia: clinical features -- Hospital-acquired pneumonia: management -- Ventilator-acquired pneumonia (VAP) -- Aspiration pneumonia -- Aspiration pneumonia: clinical features -- Lung abscess: clinical features -- Lung abscess: diagnosis -- Lung abscess: management -- Nocardiosis -- Actinomycosis -- Anthrax -- 20 Viral respiratory infection -- Viral pneumonia: overview -- Influenza -- Respiratory syncytial virus -- Parainfluenza -- Adenovirus -- Cytomegalovirus.

Herpes simplex virus -- Varicella zoster virus -- Measles -- Epstein-Barr virus -- Hantavirus -- Severe acute respiratory syndrome -- 21 Mycobacterial respiratory infection -- Tuberculosis (TB): epidemiology and pathophysiology -- TB: clinical manifestations -- Extrapulmonary tuberculosis (XPTB) -- TB: diagnostics studies -- TB: treatment -- Isolation of TB suspects and patients -- Nontuberculous (environmental) mycobacterial (NTM) lung disease -- 22 Fungal respiratory diseases -- Aspergillus lung disease: classification -- 1. Atopic allergy to fungal spores -- 2. Allergic bronchopulmonary aspergillosis -- 3. Invasive aspergillosis -- 4. Chronic necrotizing aspergillosis -- 5. Aspergilloma/mycetoma -- Pneumocystis pneumonia (PCP) -- PCP: treatment -- Endemic mycoses -- Histoplasmosis -- Blastomycosis -- Coccidioidomycosis -- Paracoccidioidomycosis -- Cryptococcosis -- Candida -- 23 Parasitic lung disease -- Hyadatidosis -- Amebiasis -- Ascariasis -- Strongyloidiasis -- Toxocara canis -- Dirofilariasis -- Schistosomiasis -- Paragonimiasis -- Tropical pulmonary eosinophilia -- 24 Pneumothorax -- Clinical features and investigations -- Initial management -- Further management -- Treatment algorithm for primary pneumothorax -- Treatment algorithm for secondary pneumothorax -- Specific situations -- 25 Pleural effusions -- Clinical features and imaging -- Malignant pleural effusion: causes and investigations -- Malignant pleural effusion: management -- Parapneumonic effusion and empyema: definition and clinical features -- Parapneumonic effusion and empyema: bacteriology and investigations -- Parapneumonic effusion and empyema: management and outcome -- Tuberculous pleural effusion -- Other causes -- 26 Asbestos and the lung -- Asbestos -- Benign asbestos-related pleural disease -- Asbestosis -- Mesothelioma: diagnosis.

Mesothelioma: treatment and outcome -- Asbestos-related lung cancer -- 27 Sleep-related respiratory disorders -- Introduction -- Obstructive sleep apnea: clinical features, pathophysiology, and consequences -- Obstructive sleep apnea: evaluation -- Obstructive sleep apnea: therapy -- Central sleep apnea -- Cheyne-Stokes respiration -- Obesity hypoventilation syndrome -- Chronic alveolar hypoventilation syndromes -- Further reading -- 28 Bronchiectasis -- Epidemiology, pathophysiology, and causes -- Clinical features and diagnosis -- General management -- Further management -- 29 Adult cystic fibrosis (CF) -- General principles -- Principles of disease management -- Management of CF lung disease -- Other pulmonary disease -- Nonpulmonary disease -- CF pulmonary exacerbation: etiology -- CF pulmonary exacerbation: antibiotics -- Management of an exacerbation -- Seeing the patient with CF in the clinic -- 30 Lung transplantation -- Background and current status -- Indications and patient selection -- Timing of referral and listing -- Surgical approaches -- Organ allocation and donor-recipient matching -- Routine post-transplant care -- Outcomes -- Complications -- 31 Pulmonary hypertension -- Classification -- Idiopathic pulmonary arterial hypertension (IPAH) -- IPAH: clinical features -- IPAH: general management -- IPAH: vasodilator therapy -- IPAH: surgical treatments, end-of-life care, and future developments -- Associated pulmonary hypertension (APH): causes -- Associated pulmonary hypertension: management -- Further information -- 32 Pulmonary thromboembolic disease -- Epidemiology and pathophysiology -- Etiology -- Clinical features -- Diagnosis of acute pulmonary embolism -- Diagnostic studies -- Management -- Special considerations -- Rare causes of embolic disease -- Future developments -- 33 Sarcoidosis -- Etiology and pathology.

Chest disease: clinical features -- Chest disease: management -- General management -- Extrathoracic disease -- 34 Idiopathic interstitial pneumonias -- Overview -- Idiopathic pulmonary fibrosis (IPF): diagnosis -- IPF: management -- Nonspecific interstitial pneumonia (NSIP) -- Cryptogenic organizing pneumonia (COP) -- Acute interstitial pneumonia (AIP) -- Respiratory bronchiolitis-associated interstitial lung disease (RB-ILD) -- Desquamative interstitial pneumonia (DIP) -- Lymphoid interstitial pneumonia (LIP) -- 35 Hypersensitivity pneumonitis -- Causes -- Diagnosis -- Management -- 36 Bronchiolitis and related disorders -- Pathophysiology and causes -- Management -- 37 Eosinophilic lung disease -- Introduction -- Eosinophilic lung disease: secondary disorders -- Eosinophilic lung disease: primary disorders, lung-limited -- Eosinophilic lung disease: primary disorders, systemic -- 38 Pneumoconioses -- Overview and causative mineral dusts -- Coal-workers' pneumoconiosis -- Silicosis -- Berylliosis -- 39 Connective tissue disease and the lung -- Differential diagnosis and standard tests to consider -- Rheumatoid arthritis (RA) -- Systemic lupus erythematosus (SLE) -- Polymyositis and dermatomyositis -- Systemic sclerosis -- Sjögren's syndrome -- Ankylosing spondylitis -- 40 Vasculitis and the lung -- Classification -- Wegener's granulomatosis: presentation and diagnosis -- Wegener's granulomatosis: management -- Microscopic polyangiitis -- Goodpasture's disease -- Churg-Strauss syndrome -- Rare pulmonary vasculitic diseases -- 41 Gastrointestinal disease and the lung -- Hepatic hydrothorax -- Hepatopulmonary syndrome -- Portopulmonary hypertension (POPH) -- Inflammatory bowel disease, celiac disease, and pancreatitis -- 42 Acute respiratory distress syndrome (ARDS) -- Pathophysiology and diagnosis -- Management and complications.

43 Upper airway diseases.